<PAGE> 1
Securities and Exchange Commission
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report January 12, 1998
----------------
(Date of earliest event reported)
COLLABORATIVE CLINICAL RESEARCH, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Ohio (000-20699) 34-1685364
- ------------------------------- --------------------- ----------------
(State or other jurisdiction of (Commission File No.) (I.R.S. Employer
incorporation) Identification No.)
20600 Chagrin Boulevard, Cleveland, Ohio 44122
- ---------------------------------------------- ----------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (216) 491-9930
--------------
Page 1 of 3 pages
Exhibit Index Appears on Page 3
<PAGE> 2
Item 5. Other Events
- --------------------
On January 12, 1998, Collaborative Clinical Research, Inc. (the "Company"),
announced that the agreement between DataTRAK, Inc. (a wholly owned subsidiary
of the Company) and IBM for joint development and marketing of a clinical trials
data management system has been terminated.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
COLLABORATIVE CLINICAL RESEARCH, INC.
By: /s/ Terry C. Black
------------------------------------------------
Terry C. Black
Vice President of Finance, Chief Financial
Officer, Treasurer, and Assistant Secretary
Date: January 15, 1998
Page 2 of 3 Pages
<PAGE> 3
EXHIBIT INDEX
EXHIBIT NO. DESCRIPTION PAGE
----------- ----------- ----
99 Press Release Issued by the Company
on January 12, 1998.
Page 3 of 3 Pages
<PAGE> 1
FOR IMMEDIATE RELEASE:
DATATRAK/IBM AGREEMENT FOR SERVICES TERMINATED
Cleveland, Ohio, January 12, 1998--Collaborative Clinical Research,
Inc., (NASDAQ: CCLR) announced today that the agreement between its DataTRAK,
Inc., subsidiary and IBM for joint development and marketing of a clinical
trials data management system has been terminated.
Collaborative Clinical Research, Inc., manages a network comprised of
over 540 affiliated multitherapeutic clinical research sites providing access to
over 3,700 principal investigators in the United States, Canada and the United
Kingdom. In addition, Collaborative operates four research facilities, conducts
Phase I through Phase IV clinical research and provides clinical reference
laboratory and Institutional Review Board services.
CONTACT: Philip A. Stark
Vice President, Corporate Development
Collaborative Clinical Research, Inc.
216/491-9930
